TITLE

IMMUNITOR ANNOUNCES POSITIVE TB TREATMENT DATA IN AFRICA

PUB. DATE
April 2011
SOURCE
Worldwide Biotech;Apr2011, Vol. 23 Issue 4, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports the results of the imm01 clinical trials of Immunitor V5 among tuberculosis (TB) patients. Results of the Immunitor V5 testing include clearance of TB bacteria from sputum within one month, re-gaining of lost weight and reduction of adverse side effects. The results were presented during the 18th Union TB and Lung Diseases Conference of the African Region held in Abuja, Nigeria. According to the article, Nigeria ranks fourth among countries where tuberculosis is prevalent.
ACCESSION #
59633531

 

Related Articles

  • Infliximab.  // Reactions Weekly;4/5/2008, Issue 1196, p22 

    The article describes two cases of tuberculous peritonitis induced by infliximab therapy in two women with rheumatoid arthritis. One of the patients developed symptoms such as abdominal pain, fever episodes and weight loss. Her conditions improved after undergoing tuberculostatic therapy. The...

  • Weight-loss drug works for teenagers, too.  // Cortlandt Forum;8/25/2005, Vol. 18 Issue 8, p16 

    Focuses on the result of a multicenter trial on the safety of orlistat drug combined with diet, exercise and behavior modification in helping obese adolescent lose weight in the U.S. Comparison between placebo an orlistat medication; Side effects of the drug; Benefits of exercise.

  • Beware the claims of the wonder drug.  // New Scientist;7/8/2006, Vol. 191 Issue 2559, p3 

    This article presents information about a new drug, rimonabant, which will help people shed weight and maintain the loss. It will also reduce risk factors for heart disease and diabetes. Rimonabant was approved by safety authorities in Great Britain in July 2006. It can help people give up...

  • A Medication Side Effect That May Be Overlooked: Unwanted Weight Loss.  // Tufts University Health & Nutrition Letter;May2002, Vol. 20 Issue 3, p8 

    Deals with the role of several drugs in unexpected weight loss among adults, such as iron supplements.

  • ADVICE GODDESS. Alkon, Amy // Missoula Independent;12/20/2012, Vol. 23 Issue 51, pC2 

    The article provides an answer to a question of how to loose the extra weight which has been gained as a result of medication side effect.

  • THUMBS-DOWN FOR TRIAX.  // Joe Weider's Muscle & Fitness;Aug2000, Vol. 61 Issue 8, p37 

    Reports on the adverse effects of Triax Metabolic Accelerator, a drug advertised as a way to lose weight by increasing metabolism. Risk of tiratricol according to the United States Food and Drug Administration; Thyroid-related symptoms of people taking the drug.

  • Kythera's ATX-101 Hits Target In Two Phase III Aesthetic Trials. Powers, Marie // BioWorld Today;4/26/2012, Vol. 23 Issue 81, p1 

    The article reports that Kythera Biopharmaceuticals Inc. has met the pre-specified primary endpoints in the European clinical trials of its lead compound ATX-101, an injectable drug aimed at reducing fats under the chin. ATX-101 showed significant efficacy than placebo in both trials....

  • Innovation! Vaughan, Roger D. // American Journal of Public Health;Aug2008, Vol. 98 Issue 8, p1353 

    The article discusses various reports published within the issue, including one fractional factorial experimental designs and another on the design of more-efficient, longer-term randomized controlled trials and other data management and statistical techniques to help detect adverse drug events...

  • Underrecognition of adverse effects. Kuritzky, Louis // Alternative Medicine Alert;Aug2010 Supplement, p15 

    The article discusses research by M. Zimmerman published in the "Journal of Clinical Psychiatry" which investigated why adverse effects related to medication are usually undetected in clinical trials.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics